Cargando…

COVID-19 Pneumonia Resembling an Acute Exacerbation of Interstitial Pneumonia

An 84-year-old man was admitted with hypoxemia and ground-glass opacities with traction bronchiectasis in both lungs and mild fibrosis on computed tomography. We first suspected that he had acute exacerbation of interstitial pneumonia and initiated methylprednisolone pulse therapy. On day 4, he was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kitayama, Takaaki, Kitamura, Hideya, Hagiwara, Eri, Higa, Katsuyuki, Okabayashi, Hiroko, Oda, Tsuneyuki, Baba, Tomohisa, Komatsu, Shigeru, Iwasawa, Tae, Ogura, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807128/ https://www.ncbi.nlm.nih.gov/pubmed/33087668 http://dx.doi.org/10.2169/internalmedicine.5630-20

Ejemplares similares

Patients with Terminal Interstitial Pneumonia Require Comparable or More Palliative Pharmacotherapy for Refractory Dyspnea than Patients with Terminal Lung Cancer
por: Okabayashi, Hiroko, et al.
Publicado: (2021)

Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 cases
por: Murohashi, Kota, et al.
Publicado: (2020)

Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy
por: Sekine, Akimasa, et al.
Publicado: (2022)

Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis
por: Yamakawa, Hideaki, et al.
Publicado: (2016)

Clinical characteristics of Japanese patients with moderate to severe COVID-19
por: Otoshi, Ryota, et al.
Publicado: (2021)

Serum Krebs von den Lungen-6 levels are associated with mortality and severity in patients with coronavirus disease 2019
por: Yamaya, Takafumi, et al.
Publicado: (2021)

A 16-year Follow-up Case of Interstitial Pneumonia with Systemic Sclerosis-rheumatoid Arthritis Overlap Syndrome
por: Yamakawa, Hideaki, et al.
Publicado: (2017)

Pneumothorax in a COVID-19 Pneumonia Patient without Underlying Risk Factors
por: Yamaya, Takafumi, et al.
Publicado: (2020)

The new useful high-resolution computed tomography finding for diagnosing fibrotic hypersensitivity pneumonitis: “hexagonal pattern”: a single-center retrospective study
por: Okabayashi, Hiroko, et al.
Publicado: (2022)

Successful treatment with afatinib following the failure of osimertinib rechallenge with osimertinib-induced interstitial lung disease: A case report
por: Sato, Yozo, et al.
Publicado: (2021)

Identification and Characteristics of Co-isolation of Multiple Nontuberculous Mycobacteria
por: Asaoka, Masato, et al.
Publicado: (2021)

Effectiveness of mepolizumab for eosinophilic pneumonia following bronchial thermoplasty
por: Otoshi, Ryota, et al.
Publicado: (2019)

Evaluation of lymphocytic infiltration in the bronchial glands of Sjögren’s syndrome in transbronchial lung cryobiopsy
por: Okabayashi, Hiroko, et al.
Publicado: (2020)

Ultra-high-resolution computed tomography can demonstrate alveolar collapse in novel coronavirus (COVID-19) pneumonia
por: Iwasawa, Tae, et al.
Publicado: (2020)

Correction to: Ultra-high-resolution computed tomography can demonstrate alveolar collapse in novel coronavirus (COVID-19) pneumonia
por: Iwasawa, Tae, et al.
Publicado: (2020)

Timeline of Oxygen Demand in Patients with COVID-19 Pneumonia
por: Oda, Tsuneyuki, et al.
Publicado: (2022)

Pemetrexed-induced Interstitial Lung Disease Mimicking Hypersensitivity Pneumonia: A Pathologically Proven Case
por: Otoshi, Ryota, et al.
Publicado: (2019)

Usefulness and safety of transbronchial lung cryobiopsy for reassessment of treatment in the clinical course of diffuse parenchymal lung disease
por: Sato, Yozo, et al.
Publicado: (2022)

Anti-Ku antibody-positive desquamative interstitial pneumonia
por: Otoshi, Ryota, et al.
Publicado: (2018)

Outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs
por: Yamaya, Takafumi, et al.
Publicado: (2022)

Significant accumulation of KRAS mutations in bronchiolar metaplasia-associated honeycomb lesions of interstitial pneumonia
por: Kataoka, Toshiaki, et al.
Publicado: (2022)

Incidence of acute exacerbation in patients with interstitial lung disease after COVID-19 vaccination
por: Sakayori, Masashi, et al.
Publicado: (2023)

Desquamative Interstitial Pneumonia Complicated with IgG4-related Lung Disease
por: Yamakawa, Hideaki, et al.
Publicado: (2017)

Pilot Quasi-Randomized Controlled Study of Herbal Medicine Hochuekkito as an Adjunct to Conventional Treatment for Progressed Pulmonary Mycobacterium avium Complex Disease
por: Enomoto, Yasunori, et al.
Publicado: (2014)

Safety and Efficacy of Combination Therapy of Remdesivir, Baricitinib, and High-dose Steroids in Patients Hospitalized with Moderate to Severe COVID-19
por: Nagasawa, Ryo, et al.
Publicado: (2023)

Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy
por: Sasano, Hajime, et al.
Publicado: (2016)

Transbronchial lung cryobiopsy in idiopathic acute fibrinous and organizing pneumonia
por: Shintani, Ryota, et al.
Publicado: (2019)

Clinical characteristics of immunoglobulin G(4)-positive interstitial pneumonia
por: Komatsu, Masamichi, et al.
Publicado: (2021)

Emphysema formation in a never-smoker with scleroderma-related interstitial pneumonia
por: Yamakawa, Hideaki, et al.
Publicado: (2018)

A Retrospective Study of the Clinical, Radiological, and Pathological Characteristics of Patients with Interstitial Pneumonia Preceding Rheumatoid Arthritis
por: Sato, Midori, et al.
Publicado: (2022)

In reply
por: Iwasawa, Tae, et al.
Publicado: (2020)

Unilateral Autoimmune Pulmonary Alveolar Proteinosis with Polymyositis-related Interstitial Lung Disease
por: Muto, Yutaka, et al.
Publicado: (2022)

Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation
por: Ishida, Yuriko, et al.
Publicado: (2022)

Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
por: Yamakawa, Hideaki, et al.
Publicado: (2018)

Interstitial Lung Disease with Anti-melanoma Differentiation-associated Protein 5 Antibody: Rapidly Progressive Perilobular Opacity
por: Chino, Haruka, et al.
Publicado: (2019)

Prognostic Factors in Interstitial Lung Disease Associated with Primary Sjögren’s Syndrome: A Retrospective Analysis of 33 Pathologically–Proven Cases
por: Enomoto, Yasunori, et al.
Publicado: (2013)

Current Treatment Strategies for Non-Small-Cell Lung Cancer with Comorbid Interstitial Pneumonia
por: Ikeda, Satoshi, et al.
Publicado: (2021)

Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosis
por: Ikeda, Satoshi, et al.
Publicado: (2019)

Low body surface area predicts hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosis
por: Ikeda, Satoshi, et al.
Publicado: (2017)

Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administration
por: Ikeda, Satoshi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ta0p7sito0rn3polvr9ipsomp3